- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2014
- Public Summary Document (PSD) March 2014 PBAC Meeting - PDF
Levonorgestrel – March 2014
Levonorgestrel, intrauterine system, 13.5 mg, Jaydess®
Last updated
8 November 2023
